Identification of glucose 6-phosphate dehydrogenase deficiency in a population with a high frequency of thalassemia

A Tagarelli1, A Piro, L Bastone

  • 1Istituto di Medicina Sperimentale e Biotecnologie-CNR, Contrada Burga, 87050, Mangone, Italy. tagare@imseb.cs.cnr.it

FEBS Letters
|January 29, 2000
PubMed

Insights

This study examined glucose 6-phosphate dehydrogenase (G6PD) deficiency and thalassemia trait in Calabria. G6PD activity in carriers is more accurately assessed by comparing them to thalassemia trait carriers, not normal subjects.

Area of Science:

  • Human Genetics
  • Biochemistry
  • Population Health

Background:

  • High prevalence of thalassemia trait (5.2%) and glucose 6-phosphate dehydrogenase (G6PD) deficiency (1.3% in males) in the Calabrian population.
  • Co-occurrence of G6PD deficiency, thalassemia trait, and total iron serum deficiency observed in the study population.

Purpose of the Study:

  • To assess G6PD activity in a Calabrian population with high frequencies of genetic anomalies.
  • To determine the most reliable method for evaluating G6PD activity in heterozygous individuals, particularly when co-occurring with thalassemia trait or iron deficiency.

Main Methods:

  • Differential pH-metry technique used for G6PD activity measurement.
  • Analysis of 1239 whole blood samples from Calabrian subjects (age 10-55).
  • Categorization of subjects based on the presence of thalassemia trait, G6PD deficiency, iron deficiency, and their combinations.

Main Results:

  • G6PD heterozygous subjects' enzymatic activity can be masked by thalassemia trait and total iron serum deficiency.
  • Comparison of G6PD activity in heterozygous subjects with thalassemia trait is more reliable when referenced against carriers of the thalassemia trait.
  • This comparative method is more accurate than referencing against G6PD activity in normal subjects.

Conclusions:

  • The study highlights the complexity of diagnosing G6PD deficiency in populations with co-existing genetic conditions like thalassemia trait.
  • A refined comparative approach is recommended for accurate G6PD activity assessment in heterozygous individuals within such populations.
  • Findings have implications for genetic screening and clinical management in regions with high carrier frequencies.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Pedigree Analysis02:21

Pedigree Analysis

A pedigree is a diagram displaying a family’s history of a trait. Analyzing pedigrees can reveal (1) whether a trait is dominant or recessive, (2) the type of chromosome, autosomal or sex, a trait is linked to, (3) genotypes of family members, and (4) probabilities of phenotypes in future generations. For families with a history of autosomal or sex-linked diseases, this information can be crucial to family planning.Pedigrees Display Family HistoriesIn various plant and animal species,...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Energy-requiring Steps of Glycolysis01:20

Energy-requiring Steps of Glycolysis

Glucose is the source of nearly all energy used by organisms. The first step of converting glucose into usable energy is called glycolysis. Glycolysis occurs in the cytosol of the cell over two phases: an energy-requiring phase and an energy-releasing phase. Over the first three steps, glucose is converted into different forms and attached to two phosphate groups donated by two ATP molecules, resulting in an unstable sugar. In the next two stages, the unstable sugar splits into two sugar...